Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7600
+0.0005 (0.07%)
At close: Jan 12, 2026, 4:00 PM EST
0.7600
0.00 (0.00%)
After-hours: Jan 12, 2026, 6:07 PM EST
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $31.03 million as of January 12, 2026. Its market cap has decreased by -33.50% in one year.
Market Cap
31.03M
Enterprise Value
-32.08M
1-Year Change
-33.50%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $31.03M, a decrease of -94.64%. That is a compound annual growth rate of -46.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 31.01M | 8.48% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |